Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● The company presents an interesting fundamental situation from a short-term investment perspective.


Strengths

● The prospective high growth for the next fiscal years is among the main assets of the company

● The company's profit outlook over the next few years is a strong asset.

● Before interest, taxes, depreciation and amortization, the company's margins are particularly high.

● Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.

● Its low valuation, with P/E ratio at 55.77 and 24.32 for the ongoing fiscal year and 2022 respectively, makes the stock pretty attractive with regard to earnings multiples.

● Given the positive cash flows generated by its business, the company's valuation level is an asset.

● The company is one of the best yield companies with high dividend expectations.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● For several months, analysts have been revising their EPS estimates roughly upwards.

● Analysts covering this company mostly recommend stock overweighting or purchase.

● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

● The opinion of analysts covering the stock has improved over the past four months.

● Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.

● The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.


Weaknesses

● Over the past twelve months, analysts' opinions have been revised negatively.

● The group usually releases earnings worse than estimated.